Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung.

Source:http://linkedlifedata.com/resource/pubmed/id/6448688

Download in:

View as

General Info

Authors

Young CW, Golbey RB, Houghton A, Kelsen DP, Gralla RJ, Casper ES

PMID
6448688